儿童抗N-甲基-D-天冬氨酸受体脑炎的临床与磁共振成像结局预测因素
该欧洲多中心队列研究纳入38例儿童抗NMDARE患者(中位年龄12.9岁),分析82次MRI并与健康对照比较。发现起病时MRI异常、感觉运动缺陷及治疗延迟>4周是临床结局不良的独立预测因素,患者存在脑容量减少和年龄预期脑生长失败。
要点
- 起病时MRI异常与不良结局相关(IRR=3.50,95%CI 1.31-9.31,p=0.012)。
- 感觉运动缺陷(OR=13.71)和治疗延迟>4周(OR=5.15)为独立预测因素。
- 患儿存在全脑、灰质、海马和基底节体积减少及脑生长失败。
核心结论
- 儿童NMDARE患者存在显著脑体积丢失和年龄预期脑生长失败。
- 起病时MRI异常、感觉运动缺陷及治疗延迟>4周与更差临床结局相关。
研究设计与样本
- 欧洲多中心队列研究,纳入38例儿童NMDARE患者(中位年龄12.9岁,范围1-18岁),共82次MRI扫描用于体积分析,并与匹配健康对照比较。
主要发现
- 起病时MRI异常见于15/38(39.5%)患者,主要为白质T2/FLAIR高信号。
- 体积MRI分析显示NMDARE患儿全脑、灰质、海马和基底节体积减少,纵向模型显示年龄预期脑生长失败。
- 起病时MRI异常患者不良结局(PCPC评分>1)发生率更高(IRR=3.50,95%CI 1.31-9.31,p=0.012)。
- 校正起病时间后,起病时MRI异常(OR=9.90,95%CI 2.51-17.28,p=0.009)、感觉运动缺陷(OR=13.71,95%CI 2.68-24.73,p=0.015)和治疗延迟>4周(OR=5.15,95%CI 0.47-9.82,p=0.031)为不良结局独立预测因素。
临床怎么用
- 起病时MRI异常、感觉运动缺陷及治疗延迟>4周可作为儿童NMDARE预后预警指标。
- 应尽早启动治疗以避免延迟>4周,并关注脑容量变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate disease symptoms, and clinical and magnetic resonance imaging (MRI) findings and to perform longitudinal volumetric MRI analyses in a European multicenter cohort of pediatric anti-N-methyl-D-aspartate receptor encephalitis (NMDARE) patients. METHODS: We studied 38 children with NMDARE (median age = 12.9 years, range =1-18) and a total of 82 MRI scans for volumetric MRI analyses compared to matched healthy controls. Mixed-effect models and brain volume z scores were applied to estimate longitudinal brain volume development. Ordinal logistic regression and ordinal mixed models were used to predict disease outcome and severity. RESULTS: Initial MRI scans showed abnormal findings in 15 of 38 (39.5%) patients, mostly white matter T2/fluid-attenuated inversion recovery hyperintensities. Volumetric MRI analyses revealed reductions of whole brain and gray matter as well as hippocampal and basal ganglia volumes in NMDARE children. Longitudinal mixed-effect models and z score transformation showed failure of age-expected brain growth in patients. Importantly, patients with abnormal MRI findings at onset were more likely to have poor outcome (Pediatric Cerebral Performance Category score > 1, incidence rate ratio = 3.50, 95% confidence interval [CI] = 1.31-9.31, p = 0.012) compared to patients with normal MRI. Ordinal logistic regression models corrected for time from onset confirmed abnormal MRI at onset (odds ratio [OR] = 9.90, 95% CI = 2.51-17.28, p = 0.009), a presentation with sensorimotor deficits (OR = 13.71, 95% CI = 2.68-24.73, p = 0.015), and a treatment delay > 4 weeks (OR = 5.15, 95% CI = 0.47-9.82, p = 0.031) as independent predictors of poor clinical outcome. INTERPRETATION: Children with NMDARE exhibit significant brain volume loss and failure of age-expected brain growth. Abnormal MRI findings, a clinical presentation with sensorimotor deficits, and a treatment delay > 4 weeks are associated with worse clinical outcome. These characteristics represent promising prognostic biomarkers in pediatric NMDARE. ANN NEUROL 2020 ANN NEUROL 2020;88:148-159.
引用
- Bartels F, Krohn S, Nikolaus M, et al. Clinical and Magnetic Resonance Imaging Outcome Predictors in Pediatric Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Ann Neurol. 2020. PMID: 32314416. doi:10.1002/ana.25754
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。